Guidance

Complete routine immunisation schedule from 1 September 2024

Updated 31 August 2024

For vaccine supply information for the routine immunisation schedule please visit ImmForm and check Vaccine Update for all other vaccine supply information.

Complete routine immunisation schedule from 1 September 2024

When Diseases protected against Vaccine given Trade name Usual site [footnote 1]
8 weeks old Diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b (Hib) and hepatitis B DTaP/IPV/Hib/HepB Infanrix hexa or Vaxelis Thigh
  Meningococcal group B (MenB) MenB Bexsero Left thigh
  Rotavirus gastroenteritis Rotavirus [footnote 2] Rotarix [footnote 2] By mouth
12 weeks old Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B DTaP/IPV/Hib/HepB Infanrix hexa or Vaxelis Thigh
  Pneumococcal (13 serotypes) Pneumococcal conjugate vaccine (PCV) Prevenar 13 Thigh
  Rotavirus Rotavirus [footnote 2] Rotarix [footnote 2] By mouth
16 weeks old Diphtheria, tetanus, pertussis, polio, Hib and hepatitis B DTaP/IPV/Hib/HepB Infanrix hexa or Vaxelis Thigh
  MenB MenB Bexsero Left thigh
One year old (on or after the child’s first birthday) Hib and Meningococcal group C (MenC) Hib/MenC Menitorix Upper arm or thigh
  Pneumococcal PCV booster Prevenar 13 Upper arm or thigh
  Measles, mumps and rubella (German measles) MMR MMRvaxPro [footnote 3] or Priorix Upper arm or thigh
  MenB MenB booster Bexsero Left thigh
Eligible paediatric age group [footnote 4] Influenza (each year from September) Live attenuated influenza vaccine LAIV [footnote 3], [footnote 5] Fluenz Tetra [footnote 3], [footnote 5] Both nostrils
3 years 4 months old or soon after Diphtheria, tetanus, pertussis and polio dTaP/IPV Boostrix-IPV Upper arm
  Measles, mumps and rubella MMR (check first dose given) MMRvaxPro [footnote 3] or Priorix Upper arm
Boys and girls aged 12 to 13 years Cancers and genital warts caused by specific human papillomavirus (HPV) types HPV [footnote 6] Gardasil 9 Upper arm
14 years old (school Year 9) Tetanus, diphtheria and polio Td/IPV (check MMR status) Revaxis Upper arm
  Meningococcal groups A, C, W and Y MenACWY MenQuadfi Upper arm
65 years old Pneumococcal (23 serotypes) Pneumococcal polysaccharide vaccine (PPV23) Pneumovax 23 Upper arm
65 years of age and older Influenza (each year from September) Inactivated influenza vaccine Multiple Upper arm
65 from September 2023 [footnote 7] Shingles Shingles vaccine Shingrix Upper arm
70 to 79 years of age (plus eligible age groups and severely immunosuppressed) [footnote 7] Shingles Shingles vaccine Zostavax [footnote 3], [footnote 7] (or Shingrix if Zostavax contraindicated) Upper arm
75 years old Respiratory syncytial virus (RSV) RSV vaccine Abrysvo Upper arm

Selective immunisation programmes

Target group Age and schedule Disease Vaccines required
Babies born to hepatitis B infected mothers At birth, 4 weeks and 12 months old [footnote 8], [footnote 9] Hepatitis B Hepatitis B (Engerix B/HBvaxPRO)  
Infants in areas of the country with tuberculosis (TB) incidence >= 40/100,000 Around 28 days old [footnote 10] Tuberculosis BCG  
Infants with a parent or grandparent born in a high incidence country [footnote 11] Around 28 days old [footnote 10] Tuberculosis BCG  
Children in a clinical risk group From 6 months to 17 years of age Influenza LAIV or inactivated flu vaccine if contraindicated to LAIV or under 2 years of age  
Pregnant women At any stage of pregnancy during flu season Influenza Inactivated flu vaccine  
  From 16 weeks gestation [footnote 12] Pertussis Tdap (ADACEL)  
  From 28 weeks gestation RSV RSV vaccine (Abrysvo)  

Additional vaccines for individuals with underlying medical conditions

Medical condition Diseases protected against Vaccines required [footnote 13]
Asplenia or splenic dysfunction (including due to sickle cell and coeliac disease) Meningococcal groups A, B, C, W and Y MenACWY
MenB
  Pneumococcal PCV13 (up to 10 years of age) [footnote 14]
PPV23 (from 2 years of age)
  Influenza Annual flu vaccine
Cochlear implants Pneumococcal PCV13 (up to 10 years of age) [footnote 14]
PPV23 (from 2 years of age)
Chronic respiratory and heart conditions (such as severe asthma, chronic pulmonary disease, and heart failure) Pneumococcal PCV13 (up to 10 years of age) [footnote 14]
PPV23 (from 2 years of age)
  Influenza Annual flu vaccine
Chronic neurological conditions (such as Parkinson’s or motor neurone disease, or learning disability) Pneumococcal PCV13 (up to 10 years of age) [footnote 14]
PPV23 (from 2 years of age)
  Influenza Annual flu vaccine
Diabetes Pneumococcal PCV13 (up to 10 years of age) [footnote 14]
PPV23 (from 2 years of age)
  Influenza Annual flu vaccine
Chronic kidney disease (CKD) (including haemodialysis) Pneumococcal (stage 4 and 5 CKD) PCV13 (up to 10 years of age) [footnote 14]
PPV23 (from 2 years of age)
  Influenza (stage 3, 4 and 5 CKD) Annual flu vaccine
  Hepatitis B (stage 4 and 5 CKD) Hepatitis B
Chronic liver conditions Pneumococcal PCV13 (up to 10 years of age) [footnote 14]
PPV23 (from 2 years of age)
  Influenza Annual flu vaccine
  Hepatitis A Hepatitis A
  Hepatitis B Hepatitis B
Haemophilia Hepatitis A Hepatitis A
  Hepatitis B Hepatitis B
Immunosuppression due to disease or treatment [footnote 15] Pneumococcal PCV13 (up to 10 years of age) [footnote 14], [footnote 16]
PPV23 (from 2 years of age)
  Shingles vaccine Shingrix – over 50 years of age [footnote 7]
  Influenza Annual flu vaccine
Complement disorders (including those receiving complement inhibitor therapy) Meningococcal groups A, B, C, W and Y MenACWY
MenB
  Pneumococcal PCV13 (up to 10 years of age) [footnote 14]
PPV23 (from 2 years of age)
  Influenza Annual flu vaccine

Translations

Translated versions of the schedule are available to download as a PDF in:

 Albanian, Arabic, Bengali, Bulgarian, Chinese (simplified), Chinese (traditional), Dari, Estonian, Farsi, French, Greek, Gujarati, Hindi, Italian, Latvian, Lithuanian, Nepali, Panjabi, Pashto, Polish, Portuguese, Romanian, Romany, Somali, Spanish, Tagalog, Tigrinya, Turkish, Twi, Ukrainian, Urdu, Yiddish and Yoruba.

  1. Intramuscular injection into deltoid muscle in upper arm or anterolateral aspect of the thigh. 

  2. Rotavirus vaccine should only be given after checking for a severe combined immunodeficiency (SCID) screening result.  2 3 4

  3. Contains porcine gelatine.  2 3 4 5

  4. See annual flu letter 

  5. If LAIV (live attenuated influenza vaccine) is contraindicated or otherwise unsuitable use inactivated flu vaccine (check Green Book chapter 19 for details).  2

  6. See Green Book HPV chapter 18a for details on immunising immunocompromised young people who will need 3 doses. 

  7. See Green Book shingles chapter 28a for details on eligible age groups including severely immunosuppressed individuals from age 50.  2 3 4

  8. Take blood for HBsAg at 12 months to exclude infection. 

  9. In addition hexavalent vaccine (Infanrix hexa or Vaxelis) is given at 8, 12 and 16 weeks. 

  10. Check SCID screening outcome before giving BCG 2

  11. Where the annual incidence of TB is >= 40/100,000 – see tuberculosis by country: rates per 100,000 people 

  12. Ideally before 32 weeks gestation but may still be given after 32 weeks. 

  13. Check relevant chapter of the Green Book for specific schedule 

  14. If aged 2 years to under 10 years of age and unimmunised or partially immunised against pneumococcal infection, give one PCV13 dose.  2 3 4 5 6 7 8 9

  15. Consider annual influenza vaccination for household members and those who care for people with these conditions. 

  16. To any age in severely immunocompromised.